Nuclide Therapeutics (private company)
See something wrong or missing? Let us know
Offices:London
Industry:
Biotech
Health services
Pharma
Business model:
B2B
Nuclide Therapeutics is a British biotech startup spun off King’s College London and focused on developing targeted radiopharmaceuticals for therapy-resistant cancers,
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 6.72m
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain